Syncona Portfolio Ltd

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 7, 2026), Syncona Portfolio Ltd reported 1 stock position worth $26.6 million. Its top holding was Autolus Therapeutics (AUTL) at 100.0% of the portfolio. Compared with Q1 2026, it sold out of 1. The biggest sale was an exit from Century Therapeutics (IPSC).

Most Recent 13F
Q2 2026
Location
St Peter Port, Guernsey, X0
CIK
0001725042
Portfolio Value
$26.6M (Q2 2026)
SEC Filing
0001193125-26-338587 ↗ filed Aug 7, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $150.1M Q1 2024 Q2 2024: $85.9M Q2 2024 Q3 2024: $80.7M Q3 2024 Q4 2024: $53.0M Q4 2024 Q1 2025: $26.4M Q1 2025 Q2 2025: $38.6M Q2 2025 Q3 2025: $27.7M Q3 2025 Q4 2025: $34.3M Q4 2025 Q1 2026: $25.7M Q1 2026 Q2 2026: $26.6M $26.6M Q2 2026

Holdings 1 stocks · $26.6M
AUTL Autolus Therapeutics PLC 100.00% 16,640,720 $26.6M No change

Portfolio Sells Q1 2026 → Q2 2026
IPSC Century Therapeutics Inc. Sold out 0.00% −10.66

Portfolio Buys Q1 2026 → Q2 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$26.6MAUTL
Q1 2026 2$25.7MAUTL, IPSC
Q4 2025 2$34.3MAUTL, IPSC
Q3 2025 2$27.7MAUTL, IPSC
Q2 2025 2$38.6MAUTL, IPSC
Q1 2025 2$26.4MAUTL, IPSC
Q4 2024 3$53.0MAUTL, ACHL, IPSC
Q3 2024 3$80.7MAUTL, ACHL, IPSC
Q2 2024 3$85.9MAUTL, ACHL, IPSC
Q1 2024 2$150.1MAUTL, ACHL